S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery
Status:
Terminated
Trial end date:
2004-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Some tumors need growth factors produced by the body to keep growing. Suramin may
interfere with the growth factor and stop the tumor from growing.
PURPOSE: Phase II trial to study the effectiveness of suramin in treating patients with stage
III or stage IV adrenocortical cancer.